Protein toxins are potent bacterial virulence factors that disrupt host cell activity, often by modulating the activity of host proteins via covalent modifications. Bacterial ADP-ribosyltransferase toxins (bARTTs) are encoded by a range of bacterial pathogens, including human pathogens, such as Corynebacterium diphtheria e, Vibrio cholerae, Bordetella pertussis, Clostridium botulinu m and Streptococcus pyogenes, the plant pathogen Pseudomona s syringae and the insect pathogen Photorhabdu s lumines cen s. Members of the bARTT family confer a single post-translational modification -the addition of ADP-ribose -on various eukaryotic substrates, including RHO proteins (for C. botulinum C3 exoenzymes 1, 2 ), heterotrimeric G proteins (for V. cholerae cholera toxin 3,4 and B. pertussis pertussis toxin 5 (PT)) and actin (for C. botulinum C2 toxin 6 ). Many of these modifications inhibit normal eukaryotic protein function; however, several novel bARTTs that activate eukaryotic proteins to promote bacterial pathogenesis have recently been identified.
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ADP-ribosylation is one of the most prevalent covalent modifications, and there are examples of ADP-ribosyltransferases in both Gram-positive and Gram-negative bacteria, as well as in eukaryotic organisms 7, 8 . These enzymes use an NAD donor molecule to catalyse the transfer of the ADP-ribose moiety to a substrate acceptor residue, which can be an Arg, Asn, Thr, Cys or Gln residue, depending on the individual toxin. At least for modification of arginine in actin, the ADP-ribosylation reaction is proposed to follow a SN1 strain-alleviation mechanism [9] [10] [11] . The bARTT family consists of >35 members, which can be divided into several discrete groups that are catalogued by their structural and functional properties, including AB domain organization and their eukaryotic protein target. Although bARTTs are typically organized into four groups on the basis of their AB domain organizations, several recently characterized bARTTs have unique AB domain organizations (TABLE 1) . The conservation of structure and function among bARTTs provides a basis for the identification of new bARTT family members using bioinformatics rather than by the identification of a disease state. The identification of bARTTs previously required the detection and purification of the protein toxin and the extrapolation of a pathogenic phenotype to the purified protein, which is often a time-consuming process. Bioinformatics provides a mechanism to predict the presence of a candidate toxin within the genomes of known pathogens and, more importantly, in bacteria that are not yet recognized as human or environmental pathogens
.
Other reviews have focused on in-depth descriptions of the mode of action of specific subgroups of bARTTs [12] [13] [14] . In this Review, we present several of the most recently identified bARTTs that were identified using bioinformatic searches. Bioinformatics has been used to identify virulence factors using different genomic screening approaches [15] [16] [17] ; however, many bioinformatic approaches require a considerable number of sequences or structures to generate data for a consensus proteinfolding domain or a conserved catalytic sequence that can then be used to predict new virulence factors. As there are more than 35 identified members and targets
SN1 strain-alleviation mechanism
An electrophilic reaction mechanism that starts with the hydrolytic release of nicotinamide from the NAD donor, followed by formation of an oxocarbenium cation intermediate in a 'strained' conformation. Rotation around the phosphodiester bond forms a second oxocarbenium cation, which results in strain relief and moving of the ribose moiety near to the acceptor residue to complete the ADP-ribose transfer.
in plants, animals and insects, the bARTT family is uniquely suited to this branch of in silico analysis 18, 19 . Bioinformatic analyses recently identified cholix toxin (ChxA) from V. cholerae, SpyA from S. pyogenes, HopU1 from P. syringae, and the Tcc toxins from P. luminescens. In this Review, we discuss the novel and conserved properties of these toxins compared with the established prototype toxins.
Structure and function of bARTTs
On the basis of toxin domain organization and conserved active-site motifs, bARTTs can be divided into two major groups: the diphtheria toxin (DT) group and the cholera toxin (CT) group. The CT group can be further subdivided into the CT-like, C2-like and C3-like bARTTs. Domain organization. DT-like toxins are ~60 kDa single-chain AB toxins that have a catalytic (A) domain and a binding (B) domain that has both receptor-binding and translocation activities [20] [21] [22] [23] (FIG. 1a) . CT-like toxins are AB5 toxins that have a ~28 kDa A domain, which is noncovalently bound to a B oligomer that comprises five non-covalently associated ~12 kDa proteins 24, 25 (FIG. 1b) .
C2-like toxins are binary toxins, which are synthesized as two separate proteins that comprise a ~50 kDa A component (known as C2I) 6 and an ~80 kDa B component (known as C2II) 26, 27 (FIG. 1c) . The C3-like exoenzymes are single-chain proteins that consist solely of a ~25 kDa A domain 28, 29 . The structural organization of the C3 A domain is remarkably similar to the catalytic domain of the C2-like toxins, despite the lack of a B component (FIG. 1d) . AexT, A. hydrophila exoenzyme T; bARTT, bacterial ADP-ribosyltransferase toxin; CDT, C. difficile transferase; ChxA, cholix toxin; Crk, CT10 regulator of kinase; CST, C. spiroforme toxin; CT, cholera toxin; DT, diphtheria toxin; eEF2, eukaryotic elongation factor 2; ERM, ezrin-radixin-moesin; ETEC, enterotoxigenic; Exo, exoenxyme; GRP7, glycine-rich RNA-binding protein 7; HB-EGF, heparin-binding epidermal growth factor; LRP1, low-density lipoprotein receptor-related protein 1; LSR, lipolysis-stimulated lipoprotein receptor; NA, not applicable; PE, Pseudomonas aeruginosa exotoxin A; photox, Photorhabdus toxin; PT, pertussis toxin; VIP, vegetative insecticidal protein. *Toxins that were initially identified using bioinformatic approaches.
P-site
(Peptidyl site). The site on the small ribosomal subunit that holds the tRNA molecule that is linked to the growing end of the polypeptide chain.
Although some recently described bARTTs share sequence and structural similarity with prototype toxins, such as ChxA, which has homology with Pseudomona s aeruginosa exotoxin A (PE) (FIG. 1e) , other recently identified bARTTs have a unique organization relative to the prototypical AB toxins. Salmonella enteric a subsp. enterica serovar Typhi expresses a novel A2B5 toxin (known as typhoid toxin (TT)), which comprises an A1 domain that has DNase activity and is joined by a disulphide bond to an A2 domain that has homology to the PT S1 catalytic domain (FIG. 1f) . The A2 domain is non-covalently bound to a pentameric B oligomer, which is a homologue of the pertussis toxin S2 binding subunit 30 . P. luminescens toxin complex (Tc) proteins have a novel ABC organization that includes one of several A subunits 31, 32 . Despite the divergence in overall organization, the ADP-ribosyltransferase domains of these new bARTTs are remarkably conserved 33 and include an invariant Glu residue, which is a key residue among the bARTTs 34 .
Active-site residues. DT-like toxins have an active-site HYE motif that contains a His residue, two Tyr residues and a Glu residue. The Glu residue was originally identified as the key catalytic residue in DT by the Collier laboratory and was eventually shown to be invariant in all bARTT s 35, 36 . Mutation of this residue results in a several-hundred-fold loss of ADP-ribosyltransferase activity and a ~10,000-fold loss in cytotoxicity 34, 37 . The invariant Glu positions the NAD for hydrolysis and coordination of the NAD-binding pocket for ADPribose transfer 38 . The HYE motif is also conserved in mammalian poly-ADP-ribosyltransferases 39, 40 . The CT group of bARTTs, which comprises the CT-like, C2-like and C3-like toxins, has a different active-site motif compared with DT; this is known as the RSE motif 29, 41, 42 and consists of an Arg residue that positions NAD in the active site, a Ser-Thr-Ser motif that stabilizes the NADbinding pocket, and a Gln(or Glu)-X-Glu motif. The Gln or Glu residue promotes the transfer of ADP-ribose to a substrate residue and, like the DT-like toxins, the second invariant Glu residue positions the NAD molecule to promote hydrolysis.
DT-like toxins DT: death after inhibition of translation. DT was discovered in 1888 following the examination of sterile culture filtrates of C. diphtheriae 43 ; injection of the filtrate into animals resulted in lesions and death that were characteristic of diphtheria, and subsequent studies correlated this pathology with DT 44, 45 . DT is encoded on a lysogenic β phage 46 and is produced by C. diphtheriae that colonize the upper respiratory tract epithelium. Lysogenized C. diphtheriae release DT, which disseminates throughout the body and targets many tissues via binding to a ubiquitous cellular receptor -heparin-binding epidermal growth factor (HB-EGF) 47, 48 (FIG. 2) . After receptor binding, the DT-receptor complex undergoes clathrin-mediated endocytosis and traffics to an early endosome 49 . Once internalized, DT is processed by host furin-like proteases, which results in a nicked di-chain that is linked by a disulphide bond 50 . Endosomal acidification promotes the insertion of two hydrophobic helices from the translocation domain of the B subunit into the membrane to deliver the A domain across the endosomal membrane, where reduction of the disulphide bond releases the A domain into the cytosol 51, 52 . DT ADP-ribosylates eukaryotic elongation factor 2 (eEF2) 53, 54 at residue 715 (REF. 55 ), which is a post-translationally modified histidine that is known as diphthamide and has been found only in archaeal EF2 and eEF2 so far 56 . ADP-ribosylation of dipthamide inhibits the function of EF2 and subsequently inhibits protein synthesis 57 . Diphthamide is located in the region of EF2 that is responsible for the interaction with the P-site (peptidyl site) of the ribosome 58 . ADP-ribosylated diphthamide may have several effects on protein synthesis, including steric hindrance of EF2 (which prevents binding to the P-site), interference with mRNA positioning 59 or decreased ribosome stability 60 . DT is extremely potent in humans and the estimated lethal dose is 100 ng per kg (REF. 61 ).
PE.
PE is an AB toxin of 613 amino acids and is closely related to DT 62 . Despite limited primary amino acid homology (there is ~18% identity between PE and DT), the A domains of PE and DT are structurally conserved and both contain the HYE motif 36, 62 . However, PE has an inverted domain orientation compared with that of DT, with the B domain at the amino terminus and the A domain at the carboxy terminus 63, 64 . PE uses lowdensity lipoprotein receptor-related protein 1 (LRP1) as a host receptor 65 (FIG. 2) . Like DT, PE is cleaved by a
Box 1 | Using bioinformatics to identify candidate bARTTs
In early work, the identification of the mechanism of action of a bacterial toxin required the use of genetic, cell biological and biochemical analyses. The subsequent classification of protein toxins into different toxin groups, including bacterial ADP-ribosyltransferase toxins (bARTTs), continued to use wet-bench approaches. However, the development of weighted bioinformatics analyses, such as Dayhoff matrices, enabled the identification of closely related bARTT variants on the basis of primary amino acid sequence conservation. The continued development of software algorithms, such as PSI-BLAST (position-specific iterative basic local alignment search tool) 187 , facilitated deeper mining for primary amino acid sequence conservation among related proteins. An increase in the number of solved protein crystal structures and the identification of protein folds and conserved amino acids within these folds using fold-recognition searches 18 has improved the ability to identify new members of the bARTT family. Although the number of protein crystal structures continues to increase exponentially, only a limited number of new protein folds have been identified 188 , which indicates that only a finite number of structural organizations can yield stable and functional protein folds.
A bioinformatics approach can correctly predict new bARTT family members on the basis of the strict conservation of a function, such as NAD binding, but is limited in its ability to correctly predict the substrate protein in the host. For example, the closely related Pseudomonas aeruginosa exoenzymes ExoS and ExoT, which share ~76% primary amino acid homology, target disparate substrates for ADP-ribosylation 126, 127, 157 . In fact, the locations of the substrate-recognition sites within ExoS and ExoT are different 158 . A more detailed characterization of how bARTTs recognize the target host protein may provide better rules to predict substrates for subgroups of bARTTs. Although this approach has primarily been used to identify new bARTTS, it may be extrapolated to other groups of virulence factors that have conserved properties, which would ultimately lead to better characterization of bacterial pathogenesis. 
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Retrograde trafficking
Trafficking of vesicles in a direction from the host cell surface to the ER; for example, trafficking from the Golgi complex to the ER.
ER-associated degradation (ERAD).
A cellular pathway that targets misfolded proteins in the ER for ubiquitylation and subsequent degradation by the proteasome.
cellular protease 66 and is internalized via clathrin-mediated endocytosis 67 but, uniquely, PE undergoes retrograde trafficking through the Golgi to the ER, mediated by a C-terminal KDEL-like sequence. Within the ER, reduction of the disulphide bond and use of the cellular ER-associated degradation (ERAD) system enables the A domain to traverse the ER membrane into the cytosol 68, 69 . Once in the cytosol, PE uses the same killing mechanism as DT -that is, the ADP-ribosylation of EF2 (REF. 70 ).
ChxA: a new V. cholerae virulence factor. ChxA was identified using bioinformatic analysis of V. cholerae genomes. V. cholerae infections are typically associated with O1 or O139 strains, which produce the CT responsible for the 'rice water' diarrhoea that is associated with this disease 71, 72 . Genome analyses of environmental 73 and clinical 74 strains of V. cholerae identified chxA, which has homology to the gene that encodes PE, toxA. Further analysis showed that approximately one-third of non-O1 and non-O139 strains encoded chxA, whereas O1 and O139 V. cholerae strains did not encode chxA, which suggests that chxA may contribute to non-CT-mediated virulence 75 . The chxA gene encodes the prototype ChxA (known as ChxA-I), which is a 666 residue protein that has a similar AB domain organization to PE 76 , with N-terminal receptor-binding and C-terminal ADP-ribosyltransferase domains 77 (FIG. 1e) . Although ChxA shares 32% amino acid identity with PE, the GC content of chxA is 43% (the GC content of the chxA-containing V. cholerae NRT36S genome is 47% 74 ) and the GC content of toxA is 69% (the GC content of the P. aeruginosa PAO1 genome is 67% 78 ). This suggests that chxA was not the product of horizontal transfer between P. aeruginosa and V. cholerae. ChxA maintains the conserved HYE motif, which is a property of the DT-like toxins, and the catalytic Glu residue is at position 581 (REF. 76 ). Full-length alignment with PE shows strong conservation of structure and function, and this was confirmed by ChxA-mediated ADP-ribosylation of EF2 (REF. 76 ). Although ChxA can use the PE receptor (that is, LRP1) 65 to enter cells, ChxA also intoxicates cells that are deficient in LRP1, which indicates that there may be a second toxin receptor 76 . Further examination of ChxA trafficking is needed to determine whether ChxA follows the same intoxication pathway as PE (FIG. 2) . In addition, ChxA has extended the therapeutic potential of the DT subfamily of toxins, as it is a potential cancer therapeutic agent
. Two recently identified ChxA variants have substantial differences in amino acid sequence within the B domain (for ChxA-II) and A domain (for ChxA-III) 75 . In vitro, ChxA and ChxA-II are toxic to several cultured cell lines, whereas ChxA-III is non-toxic, despite containing the catalytic Glu residue. Loss of toxicity may instead be due to the replacement of the KDEL ER-targeting sequence with an HDEL sequence, which could disrupt trafficking or processing steps, although this requires further testing. Injection of mice with ChxA or ChxA-II resulted in severe necrosis of the liver and death 75 .
CT-like toxins CT: cAMP signalling and fluid secretion. In 1886, Koch predicted the existence of a secreted CT 79, 80 that was eventually identified in 1959, when the injection of a sterile spent culture filtrate of V. cholerae into rabbit intestines yielded a rice water fluid accumulation that was similar to the pathology that is elicited by V. cholerae infection 81 . CT is the prototype AB5 toxin. The B subunit of CT binds to up to five molecules of the ganglioside GM1 (REF. 82 ) on the membrane of intestinal epithelial cells 83 , which may result in receptor clustering and stimulation of endocytosis 84 . Following delivery to the cytosol, the A1 domain is activated by binding to the small GTPase ADP-ribosylation factor (ARF) [85] [86] [87] and ADP-ribosylates Gα of the heterotrimeric G protein G s 88, 89 . ADP-ribosylation locks Gα s in a GTP-bound state to constitutively stimulate host adenylyl cyclase 3, 88 . This leads to increased levels of cAMP, which activates protein kinase A and, in turn, stimulates the action of a chloride ion efflux channel. This results in the secretion of ions and water into the intestinal lumen, causes the watery diarrhoea that is associated with cholera. The closely related heat-labile enterotoxin from Escherichia coli also ADP-ribosylates Gα s , which activates adenylyl cyclase [90] [91] [92] .
PT: cAMP accumulation via G i signalling. B. pertussis produces PT, which is another member of the AB5 family of bARTTs and is of current relevance owing to the resurgence of pertussis in the developed world and the worldwide infection of more than 16 million people annually 93 . PT consists of an ADP-ribosyltransferase domain (known as the S1 domain), which is non-covalently bound to a heteropentamer that is composed of four distinct subunits (known as S2-S5) 94, 95 . The B5 component of PT consists of two molecules of S4 and one molecule each of S2, S3 and S5. PT uses oligosaccharide receptors that are present on various eukaryotic proteins and has separate carbohydrate-binding sites within S2 and S3 . PT is delivered to the ER 99 , where a disulphide bond that retains S1 in an inactive conformation is reduced 100, 101 , which enables delivery into the cytosol. The S1 domain ADP-ribosylates Cys347 (REF. 5 ) on Gα of the heterotrimeric G i protein 102, 103 , which uncouples signalling from the G protein-coupled receptor 104 . This uncoupling prevents Gα i from regulating adenylyl cyclase stimulation, which results in the amplification of cAMP signalling following the activation of G protein-coupled receptors. Thus, although CT and PT both stimulate the production of cAMP, they use disparate signalling pathways to achieve this end result and have unique physiological and clinical outcomes.
C2-like toxins
Actin-ADP-ribosylating binary toxins. The reference C2-like toxins, which include C. botulinum C2 toxin 6 , Clostridium perfringens iota toxin 105 , Clostridium difficil e toxin (CDT) 106 , Clostridium spiroforme toxin (CST) 107 and Bacillus cereus vegetative insecticidal protein (VIP) 108 , are binary toxins that ADP-ribosylate actin. C2-like toxins consist of an A protein and a B protein that are secreted independently and associate on the surface of host cells. The B components are structurally and functionally related to protective antigen, which is the binding component of anthrax toxin, and form protective antigen-like heptamers 109 that translocate A proteins into the cytosol of target cells. The B proteins of iota toxin, CDT and CST bind to the same cell membrane receptor, lipolysis-stimulated lipoprotein receptor (LSR) 110 , and thus comprise a subfamily of iota-like toxins 13 . The A component comprises two ADP-ribosyltransferase domains, which probably resulted from gene duplication, one of which is inactive (that is, unable to bind to NAD) and is used as an adaptor for interaction with the binding component 111 . This family of bARTTs ADP-ribosylate monomeric G-actin at Arg177, which thereby inhibits actin polymerization and induces the depolarization of F-actin and the destruction of the actin cytoskeleton [112] [113] [114] . Interestingly, the destruction of the actin cytoskeleton may not be the only pathogenic role of these binary toxins. CDT, which is frequently found in hypervirulent C. difficile strains 115 , has unexpected effects at moderate toxin concentrations. CDT-induced ADP-ribosylation of actin is accompanied by the formation of microtubule-based cell protrusions 116 , which form a network of tentacle-like processes on the cell surface. This network embeds CDT-producing bacteria and increases their adherence and colonization. In addition, CDTinduced ADP-ribosylation of actin results in re-routing of Rab11-positive vesicles that contain fibronectin from the basolateral side to the apical side of epithelial cells, where fibronectin is released at microtubule protrusions to generate a binding site for C. difficile 117 . Similar effects on microtubules were observed with the other binary actin-ADP-ribosylating toxins 116 , which suggests that the ADP-ribosylation of actin has more sophisticated effects on host-pathogen interactions than the mere destruction of the cytoskeleton.
Actin-ADP-ribosylating toxins with novel organizations.
In addition to the binary actin-ADP-ribosylating toxins, several single-chain secreted effectors, including Salmonella spp. SpvB 118, 119 , Aeromonas hydrophila exoenzyme T (AexT) 120, 121 and P. luminescens photox 122 , have ADPribosyltransferase domains that modify eukaryotic actin with similar functional consequences for the actin cytoskeleton. These effectors were identified using bioinformatics, and this strategy is exemplified by the discovery of SpvB. The spvB gene had no known function until it was identified by PSI-BLAST (position-specific iterative basic local alignment search tool) analyses of known mono-ADP-ribosyltransferases 119 . SpvB is secreted by the Salmonella spp. type III secretion system Box 2 | Double-edged swords: use of bARTTs in therapy and research Although often considered to be damaging to human health, bacterial ADP-ribosyltransferase toxins (bARTTs) also have a remarkable capacity to contribute to positive health outcomes. The ability of bARTTs to kill cells at low doses, and particularly the extreme toxicity of diphtheria toxin (DT)-like toxins, has led to their use in various novel therapeutic and basic science applications. The toxic effects of DT ADP-ribosyltransferase activity have been used for cell ablation in transgenic mice 189 that do not express the DT receptor 47 . Expression of the DT receptor under the control of a cell-or tissue-specific promoter results in the loss of that cell type following the expression or injection of DT 190, 191 , which enables the examination of cellular functions. Other DT-like toxins have been used in the development of immunotoxins. Fusion of the catalytic domain of Pseudomonas aeruginosa exotoxin A (PE) to the variable domain of antibodies 192 enables targeting of diseased-cell markers 193 .
Immunotoxins that target CD22 (REF. 194 ), which is upregulated in B cell malignancies, have shown promise in clinical settings 195 . Immunotoxins that have been engineered with the CD4 domain that binds to the HIV envelope protein have been used to kill HIV-infected cells 196 and may be used in combination with other therapies 197 . Newer immunotoxins have been generated using the catalytic domain of cholix toxin (ChxA), which is non-reactive to PE-neutralizing antibodies 198 . The bARTTs also have roles in neuron-specific applications. Fusion of DT to the binding domain of tetanus toxin (TT) enabled delivery of cargoes to neuronal cell lines, providing a mechanism for administering neuron-specific therapies 199 . In addition, application of C3bot promotes the growth and regeneration of neurons in vitro [200] [201] [202] and in vivo 203, 204 . Increased neuronal growth and motility in a model of spinal contusion 204 indicates that this toxin could be used as a therapy to promote the regrowth of neurons in patients with damaged nervous systems. With their broad range of receptors, entry mechanisms, eukaryotic substrates and phenotypes, bARTTs will continue to be used to advance basic scientific knowledge and medical therapies.
and is required for full virulence in mice and in human macrophages 118 . The C terminus of SpvB has only 19% sequence identity to the ADP-ribosyltransferase domain of VIP2, which is the closest bARTT relative, but the typical RSE motif of C2-like ADP-ribosyltransferases was easily identified. The function of SpvB was confirmed by showing that it ADP-ribosylates actin at Arg177 (REF. 123 ). AexT was identified by bioinformatics owing to its similarities to P. aeruginosa exoenzyme S (ExoS), as it is secreted through a type III secretion system and has an N-terminal RHO GTPase-activating protein (GAP) domain and a C-terminal ARTT domain 120, 124, 125 . However, unlike ExoS 126, 127 , AexT only shows ADP-ribosyltransferase activity towards actin, which it modifies at Arg177 (REF. 121 ). AexT also shows potent RHOGAP activity towards RHO, RAC, and cell division cycle 42 (CDC42), which results in the synergistic promotion of actin cytoskeleton depolymerization 128 . Photox, which is a two-domain protein from P. luminescens, was identified using BLAST analysis, which revealed that is has 39% overall sequence identity with SpvB 122 . The C-terminal domain of photox shares 61% identity with the ARTT domain of SpvB and, similarly, photox modifies Arg177 of actin. Secretion of photox occurs via an as-yet-unidentified mechanism; however, photox contains a unique N-terminal domain of unknown structure and function, which may contribute to secretion.
C3-like toxins
C3bot: uncoupling RHO signalling. C3 exoenzymes have a single-domain organization, which consists solely of an ADP-ribosyltransferase A domain. C3-like toxins ADP-ribosylate RHO-family GTPases, primarily RHOA, RHOB and RHOC 1, 129, 130 . RHO GTPases are low molecular weight G proteins that modulate the state of actin polymerization by cycling between GTP-bound active and GDP-bound inactive states via interactions with guanine nucleotide exchange factors (GEFs) and GAPs (FIG. 3a) . Binding of RHO-family GTPases to GTP promotes their association with downstream effector proteins, which primarily results in the modulation of cellular polarity by CDC42, the modulation of cell morphology and motility by RAC and the modulation of actin stress fibres by RHO 131 . However, RHO proteins also effect changes in adhesion, morphogenesis, vesicular trafficking, microtubule dynamics and gene expression 132 . C3bot ADP-ribosylates RHO on Asn41 at the edge of the switch-I region 133 , which typically undergoes a conformational change with GDP and GTP nucleotide cycling. In contrast to the ADP-ribosylation of substrates by other bARTTs, which inhibits interactions with effector proteins, ADP-ribosylated RHO can still interact with effectors 134 but has an increased affinity for RHO guanine nucleotide dissociation inhibitor (GDI) 135 , which sequesters RHO in the cytoplasm and prevents its activation by RHOGEFs 136 (FIG. 3a) . High-affinity binding to RHOGDI blocks the polymerization of actin stress fibres and collapses the cytoskeleton. C3bot also interacts with the RAS-related GTPase RAL. C3bot does not ADP-ribosylate RAL but, via high-affinity binding, it prevents nucleotide exchange and activation of RAL in a GDI-like manner 137 . The functional consequences of C3-RAL complex formation are unclear.
As C3 exoenzymes do not have a B domain, entry into host cells occurs via other pathways; for example, C3Stau/EDIN 138 from Staphylococcus aureus is proposed to be secreted into the host cytoplasm following internalization of the bacteria by HeLa cells 139 , whereas other C3 homologues are taken up by macrophagelike cells 140 . The entry of each C3 toxin may represent a directed mechanism to inhibit the phagocytic activity of specific cells. Intriguingly, C3bot also seems to have a role in stimulating neuron growth and regeneration, which suggests that it may have therapeutic potential
. Recent bioinformatic analyses have discovered new C3-like toxins that have novel substrate specificities and pathogenic mechanisms. 
Intermediate filament
A filament that is formed by coiled-coil-rich cytoskeletal proteins, such as keratin.
Pattern recognition receptors
(PRRs). Soluble or membraneassociated receptors that are displayed by the metazoan host and can recognize complex molecular patterns on the surface of microorganisms.
SpyA: a membrane-anchored bARTT. S. pyogenes is a Gram-positive human pathogen and is the primary agent of Group A streptococcal infections, which cause a spectrum of diseases that range from mild pharyngitis (known as strep throat) to streptococcal toxic shock syndrome, which, if untreated, can be fatal within hours. Recognized S. pyogenes virulence factors include adhesin-like molecules, a hyaluronic acid-containing capsule and superantigen toxins 141 . Genome sequencing has identified >40 putative virulence-associated genes, including spyA, which encodes a candidate ADP-ribosyltransferase 142 . The genomes of multiple clinical isolates of S. pyogenes contain spyA, which suggests that SpyA may have a role in pathogenesis in humans 143 . Sequence analysis predicted that SpyA would have C3-transferase activity; spyA encodes a 25 kDa protein that consists of 250 amino acids and a putative 30-residue leader sequence. Unexpectedly, SpyA was not detected in S. pyogenes culture supernatants; instead, the predicted leader sequence formed a transmembrane helix and was inserted into the bacterial outer membrane 144 . SpyA contains a C3-like RSE motif, and the predicted catalytic Glu is at position 187 (REF. 143 ). Although bioinformatics data suggested that SpyA was a C3-like toxin, recombinant SpyA did not ADP-ribosylate RHO GTPases, but instead ADP-ribosylated vimentin, with actin as a minor substrate 143 . These substrates are also targeted by other bARTTs: C2-like toxins ADP-ribosylate actin 6 and ExoS of P. aeruginosa ADP-ribosylates vimentin 126 . Vimentin is a highly conserved multifunctional intermediate filament protein that is involved in promoting cell adhesion and integrating signalling pathways and is key in the organization of cellular architecture 145 . Vimentin consists of a central coil domain that is flanked by head and tail domains and forms antiparallel dimers and tetramers, depending on the head-tail phosphorylation state. Vimentin also has a role in the migration of immune cells, and loss of vimentin function results in impaired wound healing 146 . Stoichiometric analysis showed that SpyA ADP-ribosylated vimentin at two arginine residues: Arg44 and Arg49 (REF. 147 ). These residues are located in the head domain of vimentin, and modification of residues in the head domain prevents vimentin from forming higherorder structures 148 . ADP-ribosylation probably blocks the oligomerization of vimentin into intermediate filaments, which results in the disruption of vimentin filaments and cytoskeletal collapse 147 . SpyA contributes to S. pyogenes pathogenesis in vivo, as a SpyA-deficient mutant is internalized more readily by HeLa cells and causes smaller bacterial lesions than SpyA-containing bacteria in a mouse cutaneous infection model 149 .
SpyA is an excellent example that shows both the strengths and limitations of bioinformatics. Bioinformatics correctly predicted that SpyA was a bARTT, but its initial classification as a C3-like transferase was not entirely correct. SpyA ADP-ribosylates a different subset of eukaryotic proteins to promote bacterial survival and virulence and, unlike other C3-like toxins, is anchored in the bacterial membrane to promote bacterial pathogenesis.
HopU1: modulator of plant immunity. The bARTT family is not limited to human pathogens. P. syringae infects >50 species of plants using >30 type III secreted effector proteins [150] [151] [152] , most of which are of unknown function. Bioinformatic analysis of the P. syringae genome, which was sequenced in the early 2000s 153, 154 , identified a putative bARTT, denoted HopU1, which was predicted to be a 264 amino acid protein with a conserved RSE motif 155 (FIG. 3b) . Although the domain fold of HopU1 has high overall similarity to C3bot, the two proteins share only 19% amino acid identity. In addition, HopU1 contains two unique loops, known as L1 and L4 (FIG. 3b) , which are not present in other bARTTs and which have been implicated in substrate recognition and binding 156 . The mutation of key residues in L1 or L4 results in loss of substrate binding and ADP-ribosylation, which suggests that unique loops outside the core NAD-binding pocket may define substrate specificity in these toxins 156 . This is similar to CT10 regulator of kinase (Crk) recognition by another C3-like toxin, ExoT of P. aeruginosa , whereby an α-helix that is adjacent to the NAD-binding pocket contains the site of substrate recognition 158 . Like SpyA, HopU1 does not ADP-ribosylate RHO proteins. Instead, HopU1 ADP-ribosylates glycine-rich RNA-binding protein 7 (GRP7) 155 . GRP7 is involved in processing mRNA and promoting mRNA stability within plant cells 159 as well as in interacting with components of the translational machinery 160 . Loss of GRP7 function results in increased susceptibility to pathogens 155, 156 , which suggests that it has a role in mediating the immune response to infection. HopU1 ADP-ribosylates GRP7 at Arg49 (REF. 155 ) in conserved ribonucleoprotein consensus sequence 1 (RNP1), which has been implicated in RNA binding in other proteins 161, 162 . Arg49 forms a salt bridge with the RNA phosphate backbone, which promotes transcript stability 163, 164 , and a point mutation at Arg49 results in a decrease in the mRNA-binding affinity of GRP7 (REF. 165 ). GRP7 binds to various mRNA transcripts in vivo, including mRNAs that encode the pattern recognition receptors (PRRs) FLS2 and EFR 160 . PRRs are a part of the plant innate immune system 166, 167 and are responsible for recognizing pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS), peptidoglycan and bacterial proteins, such as flagellin and bacterial elongation factor-Tu. Bacterial activation of PRRs results in a PAMP-mediated immune response that upregulates the production of reactive oxygen species and the expression of innate immunity genes 168 . Therefore, HopU1 inhibits binding and stabilization of the PRR transcripts by GRP7, which results in the downregulation of PRR protein expression and the suppression of plant immunity 160 . The ability to limit the inhibition of translation to proteins of the innate immune system contrasts with the total inhibition of protein synthesis and cell death that is caused by the DT-like bARTTs. In this way, P. syringae, which is a biotrophic pathogen, suppresses the host immune response but spares the life of the host cell. As with SpyA, although bioinformatic analyses correctly identified HopU1 as a novel bARTT, the substrate and mechanism of HopU1 activity were solved by conventional cell biology and biochemical approaches. 
Paracrine
A term used to describe the activation of cellular receptors on cells adjacent to the cell that produces the ligand.
Novel bARTTs
Typhoid toxin: a novel chimaera with dual activities. S. Typhi is the causative agent of typhoid fever, which kills ~200,000 people annually 169 . Until recently, the virulence factors that contribute to systemic infection with S. Typhi were not well understood. Bioinformatic analysis of the S. Typhi genome identified a gene (known as cdtB) that has similarity to genes that encode cytolethal distending toxins, which are expressed by several other bacterial pathogens 170 . However, although the putative A component CdtB showed DNase activity when transiently expressed within cultured cells, there did not seem to be a corresponding B component. Deeper sequence analysis of the pathogenicity islet that contains cdtB identified two additional genes, pltA and pltB, which show similarity to the sequences of the PT S1 and S2 subunit genes, respectively 171 . Unexpectedly, all three proteins were produced during S. Typhi intracellular infection of mammalian cells, and deletion of pltA or pltB eliminated cdtB-mediated pathology, which links the three gene products. The holotoxin was termed typhoid toxin (TT), after the disease that is caused by S. Typhi. Crystallization of TT showed a novel 2AB5 domain organization in which the 2A domain comprises one unit of CdtB and one unit of PltA and the B5 domain comprises five PltB subunits 30 (FIG. 1f) . CdtB and PltA are joined by a disulphide bond that is formed by two unique cysteine residues that are not present in PT or other cytolethal distending toxins. PltA and PltB interact via the insertion of a short PltA α-helix into the PltB B5 pentamer (FIG. 1f) . PltB and CdtB do not seem to have direct contact 30 . Purified TT binds to a broad range of gangliosides as cellular receptors and has a preference for the disialic acid moiety on GD2. Intoxication of mice with TT caused symptoms that were similar to typhoid fever, including weight loss, depletion of neutrophils and death 30 . Although PltA has significant structural homology to the pertussis S1 subunit, PltA ADP-ribosyltransferase activity targets an as-yet-unidentified protein. Each of the three components of TT is expressed by intracellular S. Typhi but not by S. Typhi that is cultured alone in liquid media 171 . Interestingly, growth media from S. Typhi-infected cells had cytolethal distending toxicity, which indicates that full-length TT is secreted into the extracellular media 171 . Subcellular studies showed that each of the three components of TT colocalized in membrane-bound vesicles, which presumably contribute to the delivery of the toxin to the extracellular media 171 . Addition of a TT-neutralizing antibody blocked toxic effects on neighbouring cells and toxicity within S. Typhi-infected cells, which indicates that TT may use both autocrine and paracrine intoxication pathways (FIG. 4) . A recent report suggests that TT is packaged into LPS-containing vesicles, which are then released into the extracellular medium; the TT-containing vesicles are then taken up by neighbouring cells via dynamin-dependent endocytosis and TT is delivered via a Golgi-mediated pathway 172 . Although the bioinformatics prediction that TT was similar to the cytolethal distending toxins and pertussis toxin was confirmed by crystallographic analyses, the novel structural organization and toxin delivery mechanism were not predicted. In addition, the cellular target of PltA ADP-ribosyltransferase activity has not been identified, despite its homology to pertussis toxin S1, which again shows the limits of current bioinformatic analyses.
TccC proteins. Insect pathogens also express bARTTs. Large (>1.5 MDa) tripartite toxin complexes, known as Tc or ABC toxins, are produced by entomopathogenic P. luminescens, which lives in symbiosis with nematodes (such as Heterorhabditis spp.) [173] [174] [175] . Nematodes that harbour the bacteria in their intestines invade insect larvae and release the bacteria by regurgitation. Once released into the insect haemocoel, the bacteria produce a range of toxins to kill the insect, which generates an enormous source of nutrients for the proliferation of bacteria and nematodes. When the larvae have been depleted, the nematodes take up the bacteria and then invade new insect prey 175 . Tc toxin, which consists of three components, TcA, TcB and TcC, is one of the most potent toxins that is produced by P. luminescens 176, 177 . TcA (which is 285 kDa) is the cell-binding and translocation B component and forms B pentamers 178 . TcC (which is ~105 kDa) is the biologically catalytic A component. Like TcA and TcB, there are several isoforms of TcC 179 , and it consists of a highly conserved N-terminal region of 660-680 amino acids and a C-terminal variable region of about 300 residues. TcB (which is 170 kDa) is a linker between TcA and TcC. Using bioinformatics, the variable regions of TcC were identified as bARTTs with typical RSE motifs 31 . In the presence of TcA and TcB, TccC3 induces the clustering of F-actin in insect and mammalian cells. TccC3 ADP-ribosylates actin at Thr148, and the ADP-ribose attachment is located in the binding site of thymosin β4, which normally sequesters monomeric actin 180, 181 . Thus, ADP-ribosylation blocks the binding of thymosin β4, and the polymerization of actin is induced. Component TccC5 also strongly induces the formation of stress fibres in the presence of TcA and TcB, although this occurs via a different mechanism 31 (FIG. 3a) . In contrast to the C3 toxins, which inactivate RHO signalling via the ADPribosylation of Asn41 in the switch-I region of RHO proteins, TccC5 ADP-ribosylates RHO GTPases at Gln61 or Gln63, which are located in the switch-II region 31 . Conformational changes in the switch-II region are crucial for GTP hydrolysis 182 , and TccC5 ADP-ribosylation locks RHO proteins into a constitutively active form, which results in the activation of RHO kinase and/or formins to induce the formation of stress fibres 31 . Therefore, the Tcc proteins function antagonistically to the other bARTTs that target the RHO proteins or actin, which inhibit protein function and block actin polymerization. TccC3-and TccC5-induced actin polymerization also inhibits the function of immune cells that are present in the haemocoel of insects (for example, by blockade of phagocytosis).
The crystal structures of the components of the Tc toxin have recently been solved 183 and show that TcA forms a pentameric prepore structure that consists of a central channel, which is shaped like a flared funnel, and an outer shell compartment, resulting in a bell-like structure. The crystal structure of the TcdB2-TccC3 complex shows a huge β-barrel-shaped cage, and the ADP-ribosyltransferase domain is in an unfolded form within the cage. The top of the barrel is closed by a highly conserved rearrangement hotspot (RHS) repeat-associated domain. An aspartate protease domain is located in this region, which probably cleaves the already unfolded C-terminal ADP-ribosyltransferase domain of the TcC component and is released into the β-barrel-shaped cage. Once released, TcC can be injected into host cells by the TcA B-pentamer syringe.
Conclusions
This research area has changed considerably over the past decade owing to the advent of bioinformatics.
Members of the bARTT family can be identified from genome sequences and can be experimentally tested without any prior association with disease. However, although bioinformatics provides a starting point for the identification of putative virulence factors, Falkow's molecular Koch's postulates should still be considered for definitive identification 184, 185 . To show that the determinant that has been identified using bioinformatics has a role during infection, it is important to demonstrate that the putative virulence factor is expressed only in a pathogenic genus or strain and that deletion or mutation of the gene that encodes the proposed virulence factor results in a loss of pathogenicity. Replacement or restoration of the wild-type gene should then be shown to restore the pathogenic phenotype. These guidelines should be used to prioritize the increasing number of putative toxins and other virulence factors that are being identified using bioinformatic methods. Following these guidelines will ensure that the most important virulence determinants are investigated and that therapies or vaccines are targeted against the most important molecules.
As the large number of identified bARTTs enables the rigorous formulation of conserved structural and sequence determinants with which to identify new toxins from sequenced genomes, the bARTT family shows the power of bioinformatics to identify new toxins on the basis of in silico analyses. Although bioinformatics has been used to identify other putative virulence factors 16 , the number of available data sets for each group of virulence factors is limited when compared with the number of identified bARTT sequences and available crystal structures 186 . However, although the ability to predict a bARTT is strongly supported, this predictive capability is reduced when the aim is to identify the substrate. In the near future, the discovery of new members of the bARTT family, using fold-recognition searches on the basis of the conserved NAD-binding domain and key amino acid residues, will have an increasingly important role in advancing the field. The increasing number of bARTT family members will provide greater power to predict and study the properties of these toxins and may establish more defined rules for these determinations and better prediction of toxin substrates. These rules may eventually be extrapolated to other less well-characterized families of protein virulence determinants and increase our understanding of bacterial pathogenesis. 
